New Research Uncovers How Retinoic Acid Targets Metastatic Neuroblastoma Cells
Source: Inside Precision Medicine
BMP has heightened activity in neuroblastoma cells in the bone marrow making them more susceptible to retinoic acid.
Scientists at St. Jude Children’s Research Hospital have shown that the bone morphogenetic protein (BMP) signaling pathway plays a crucial role in making metastatic neuroblastoma cells susceptible to treatment with retinoic acid. Treating patients wi… [3377 chars]